Treatment Patterns
Cross-source consensus on Treatment Patterns from 1 sources and 5 claims.
1 sources · 5 claims
Uses
Comparisons
Highlighted claims
- During full follow-up, 83.0% of patients received at least one SARD-ILD-related pharmacological treatment of interest. — Post-progression treatment patterns in systemic autoimmune rheumatic disease-associated interstitial lung disease: insights from a US retrospective, observational study
- Oral corticosteroids were the most frequently used pharmacological therapy after progression. — Post-progression treatment patterns in systemic autoimmune rheumatic disease-associated interstitial lung disease: insights from a US retrospective, observational study
- Antifibrotic treatment was uncommon after progression. — Post-progression treatment patterns in systemic autoimmune rheumatic disease-associated interstitial lung disease: insights from a US retrospective, observational study
- Non-biologic DMARDs were the second most common drug class after progression. — Post-progression treatment patterns in systemic autoimmune rheumatic disease-associated interstitial lung disease: insights from a US retrospective, observational study
- The findings showed high corticosteroid reliance and comparatively limited use of disease-modifying therapies and antifibrotics after progression. — Post-progression treatment patterns in systemic autoimmune rheumatic disease-associated interstitial lung disease: insights from a US retrospective, observational study